Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Tirbanibulin Suppresses HPV Oncoproteins and Cell Growth in
2026-07-31
This study demonstrates that tirbanibulin markedly inhibits proliferation of HPV-18–positive HeLa cells and downregulates a range of oncogenic proteins, including HPV E6/E7 and components of the Src-MEK signaling pathway. The work provides mechanistic insight into tirbanibulin's antiproliferative effects and suggests new research directions for HPV-associated malignancies.
-
Tetrandrine Alkaloid: Mechanisms and Protocols for Ion Chann
2026-07-31
Tetrandrine is a potent, DMSO-soluble alkaloid that modulates calcium channels and is widely used in ion channel and cancer biology research. Its precise mechanism, rigorous storage requirements, and reproducible performance make it a benchmark tool for pharmacological and signaling pathway studies. This article synthesizes current evidence, clarifies application boundaries, and details validated protocol parameters.
-
TLS-Mediated B Cell Activation in ESCC via CD40-STING-TRAF2-
2026-07-30
This study unveils how tertiary lymphoid structures (TLS) drive antitumor immunity in esophageal squamous cell carcinoma (ESCC) through competitive binding of CD40 and STING with TRAF2, leading to IRF4-mediated B cell activation. The findings provide mechanistic insight into TLS function, suggesting new biomarkers and therapeutic strategies for ESCC.
-
SB-505124 Hydrochloride: Transforming Fibrosis and Cancer Re
2026-07-30
This thought-leadership article explores the mechanistic power and translational promise of SB-505124 hydrochloride, a selective TGF-β/activin pathway inhibitor. By dissecting its role in modulating cellular stiffness, fibrosis, and cancer metastasis, it offers actionable insights for researchers aiming to bridge molecular insights with clinical innovation, and sets a new benchmark for rigor and strategic foresight in the use of ALK inhibitors.
-
Peptidisc-Assisted Nanobody Multimerization: Expanding Prote
2026-07-29
Chen and Duong van Hoa introduce a peptidisc-based method for assembling multimeric and multispecific nanobody complexes, termed polybodies. This strategy leverages hydrophobic clustering stabilized by peptidiscs, enhancing stability and functionality in nanobody engineering and offering a detergent-free alternative to existing multimerization approaches.
-
PYR-41: Applied Workflows for Ubiquitin-Activating Enzyme E1
2026-07-29
PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect ubiquitin-proteasome system dynamics in real time. This guide details optimized workflows, advanced troubleshooting, and unique assay choices for translational inflammation and virology models.
-
PF-573228: FAK Inhibitor Workflows for Mechanotransduction &
2026-07-28
PF-573228, a gold-standard FAK inhibitor from APExBIO, empowers researchers to dissect how substrate stiffness and cell adhesion cues drive signaling in cancer and tissue engineering. This guide covers actionable protocols, troubleshooting, and advanced applications, bridging recent mechanotransduction breakthroughs with robust experimental design.
-
AMPK Suppresses Autophagy: Revisiting Energy Stress Response
2026-07-28
This study overturns the prevailing model by demonstrating that AMPK, rather than universally inducing autophagy, actively suppresses the autophagy-initiating kinase ULK1 during energy stress. These findings reshape our understanding of energy metabolism regulation and have significant implications for experimental approaches in metabolic and autophagy research.
-
Nifedipine (BAY-a-1040) in Calcium Influx and Liver Regenera
2026-07-27
Nifedipine (BAY-a-1040) is a precision L-type calcium channel blocker enabling advanced studies of calcium-dependent signaling, iron metabolism, and fungal pathogenesis. This article unpacks stepwise experimental workflows, highlights protocol nuances, and contextualizes Nifedipine within the expanding landscape of liver regeneration and drug metabolism models.
-
Silver Nanoparticles Trigger Ferroptosis-Mediated Liver Infl
2026-07-27
This study elucidates how silver nanoparticles (AgNPs) induce liver inflammation in zebrafish through ferroptosis, identifying key genes involved and linking the process to glucose metabolism disruption. The findings advance mechanistic understanding of nanomaterial-induced hepatotoxicity and inform toxicological risk assessment strategies.
-
Protein A/G Magnetic Beads: Protocols and Best Practices
2026-07-26
Protein A/G Magnetic Beads (SKU K1305) enable high-specificity antibody isolation and protein-protein interaction studies in complex biological samples. These beads are ideal for immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation (Ch-IP) workflows where non-specific binding is a concern. They are not suitable for diagnostic or clinical applications.
-
Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons
2026-07-25
This study establishes a scalable in vitro system for HSV-1 latency and reactivation using human iPSC-derived sensory neurons, overcoming previous limitations of animal-derived models. The approach enables detailed investigation into the neuron-intrinsic mechanisms governing herpesvirus latency and offers a human-relevant platform for testing potential interventions.
-
Viral Control of RIPK3 Degradation Shapes Host Inflammatory
2026-07-24
This study uncovers a class of viral proteins that induce degradation of the necroptosis adaptor RIPK3, allowing orthopoxviruses such as cowpox virus to suppress host inflammatory cell death. The findings reveal how targeted manipulation of ubiquitin pathways by viruses regulates inflammation and pathogenesis, with implications for future antiviral and immunology research.
-
Viral Induction of RIPK3 Degradation Modulates Necroptosis
2026-07-24
Liu et al. identified a class of orthopoxvirus proteins that induce targeted degradation of RIPK3, thereby suppressing necroptosis and modulating virus-induced inflammation. This mechanistic insight advances our understanding of host-pathogen interactions and highlights the central role of the ubiquitin-proteasome system in regulating antiviral immune responses.
-
Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model
2026-07-23
A recent study demonstrates that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively suppresses triple-negative breast cancer by triggering ferroptosis through CUL3-mediated ubiquitination of MTDH. These findings establish a mechanistic basis for using Gramine as a research tool to interrogate ferroptosis pathways in aggressive cancer subtypes.